1. Home
  2. APGE vs CRGY Comparison

APGE vs CRGY Comparison

Compare APGE & CRGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • CRGY
  • Stock Information
  • Founded
  • APGE 2022
  • CRGY 1986
  • Country
  • APGE United States
  • CRGY United States
  • Employees
  • APGE N/A
  • CRGY N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • CRGY Oil & Gas Production
  • Sector
  • APGE Health Care
  • CRGY Energy
  • Exchange
  • APGE Nasdaq
  • CRGY Nasdaq
  • Market Cap
  • APGE 2.1B
  • CRGY 2.5B
  • IPO Year
  • APGE 2023
  • CRGY N/A
  • Fundamental
  • Price
  • APGE $44.32
  • CRGY $9.13
  • Analyst Decision
  • APGE Strong Buy
  • CRGY Buy
  • Analyst Count
  • APGE 4
  • CRGY 12
  • Target Price
  • APGE $97.50
  • CRGY $16.40
  • AVG Volume (30 Days)
  • APGE 913.3K
  • CRGY 3.5M
  • Earning Date
  • APGE 08-11-2025
  • CRGY 08-04-2025
  • Dividend Yield
  • APGE N/A
  • CRGY 5.24%
  • EPS Growth
  • APGE N/A
  • CRGY N/A
  • EPS
  • APGE N/A
  • CRGY N/A
  • Revenue
  • APGE N/A
  • CRGY $3,223,618,000.00
  • Revenue This Year
  • APGE N/A
  • CRGY $25.73
  • Revenue Next Year
  • APGE $743.14
  • CRGY N/A
  • P/E Ratio
  • APGE N/A
  • CRGY N/A
  • Revenue Growth
  • APGE N/A
  • CRGY 31.58
  • 52 Week Low
  • APGE $26.20
  • CRGY $6.83
  • 52 Week High
  • APGE $63.50
  • CRGY $16.94
  • Technical
  • Relative Strength Index (RSI)
  • APGE 61.88
  • CRGY 51.94
  • Support Level
  • APGE $42.88
  • CRGY $8.49
  • Resistance Level
  • APGE $44.61
  • CRGY $9.13
  • Average True Range (ATR)
  • APGE 2.37
  • CRGY 0.37
  • MACD
  • APGE 0.12
  • CRGY -0.05
  • Stochastic Oscillator
  • APGE 63.45
  • CRGY 42.62

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About CRGY Crescent Energy Company

Crescent Energy Co is an independent energy company with a portfolio of assets in key basins across the lower 48 states. The company maintains a diverse portfolio of assets in key basins across the United States, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con. It seeks to deliver attractive risk-adjusted investment returns and predictable cash flows across cycles with a focus on operated oil and gas assets complemented by non-operated assets, mineral and royalty interests, and midstream infrastructure.

Share on Social Networks: